Thanks for sharing! Interesting and had some new i
Post# of 148267
1) mono pivotal trial 48 weeks and estimated approval around 2021
2) initiating NASH preclinical trial (most small NASH companies have $1B MC)
3) interim clinical TNBC results 4-5 months
4) BLA submission July-Oct (thought this may move up with the 525 results, but instead added a month to the worst case)
5) NP going to S Korea and potential to increase deal to $10B eventually ($250M I understood as costs which would be 2.5% likely at $120k price tag).
I’ll listen again, but this was my initial takeaway.